Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 4/20 | 0.56 |
| ▸ | CTRB1 | P17538 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | PTGFR | P43088 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6638897 | 0.87 | CTRB1 (0.54) | ELANECTRB1ALDH1A1KMT2AMEN1 | |
| SCHEMBL6635955 | 0.87 | ELANE (0.56) | ELANECTRB1ALDH1A1KMT2AMEN1 | |
| SCHEMBL6636305 | 0.86 | ELANE (0.56) | ELANECTRB1PCSK9 | |
| SCHEMBL6640855 | 0.84 | CTRB1 (0.57) | ELANECTRB1ALDH1A1KMT2AMEN1 | |
| SCHEMBL6637536 | 0.84 | CTRB1 (0.50) | ELANECTRB1ALDH1A1KMT2AMEN1 | |
| SCHEMBL6636501 | 0.83 | CTRB1 (0.58) | ELANECTRB1ALDH1A1KMT2AMEN1 | |
| SCHEMBL6638769 | 0.83 | ELANE (0.55) | ELANECTRB1KMT2APOLBPCSK9 | |
| SCHEMBL6717299 | 0.82 | CTRB1 (0.54) | ELANECTRB1ALDH1A1KMT2AHTT | |
| SCHEMBL6635695 | 0.82 | ELANE (0.53) | ELANECTRB1ALDH1A1KMT2AMEN1 | |
| SCHEMBL6713458 | 0.81 | ELANE (0.53) | ELANECTRB1ALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040116420-A1 | Remedial agent for viral infectious disease | ASAHI KASEI PHARMA CORPORATION (JP) | 2004-06-17 | — | — | US | disclosed |